Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

“A Phase II trial of atezolizumab plus CArboplatin plus nab-Paclitaxel as first-line Therapy in metastatic triple-negative PD-L1 positive br… Recruiting

2024-519514-31-00 metastatic triple-negative PD-L1 positive breast cancer 4 2025-01-31
ANALYSIS OF EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED COLON CANCER. Recruiting

2024-519825-39-00 Locally advanced colon cancer (LACC) 4 2025-01-30
A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) an… Recruiting

2024-512900-20-00 Non-muscle invasive bladder cancer (NMIBC) 7 2025-01-30
A first-in-human, dose escalation and dose expansion study of SAR445877 in adult participants with advanced solid tumors Recruiting

2023-507141-28-00 Solid tumor 7 2025-01-29
Study of ORIC-114 in Patients with Advanced Solid Tumors Harboring an EGFR or HER2 Alteration Recruiting

2024-512264-66-00 Solid Tumors 7 2025-01-29
FAPI PET in Pleural Mesothelioma Recruiting

2024-514301-62-00 Pleural Mesothelioma 4 2025-01-29
A trial to learn if Dato-DXd with rilvegostomig, or rilvegostomig alone, is safe and works compared with pembrolizumab in people who have ad… Recruiting

2023-505077-32-00 Locally-advanced or metastatic non-squamous non-small c 5 2025-01-28
A phase 3 study to evaluate petosemtamab vs. investigator's choice in previously treated metastatic / recurrent head and neck cancer. Recruiting

2023-510322-32-00 patients with incurable, metastatic/recurrent head and 5 2025-01-27
Effect of oxygen administration in the non-dependent lung on postoperative complications after lung surgery Recruiting

2024-517599-39-00 Lung Resection Surgery 6 2025-01-27
RAXO trial - A population-based prospective study to evaluate clinical behaviour, resectability and survival in metastatic colorectal cancer… Recruiting

2024-520288-15-00 Metastatic or locally advanced inoperable colorectal ca 6 2025-01-25
PET imaging of CD8 T lymphocyte recruitment induced by radiotherapy locally and remotely Recruiting

2024-517640-57-01 Patients with polymetastatic solid cancers. 1 2025-01-24
A phase 3 study to evaluate petosemtamab plus pembrolizumab vs pembrolizumab in first-line treatment of head and neck cancer Recruiting

2023-510323-30-00 First-line treatment of recurrent or metastatic PD-L1+ 5 2025-01-24
Continued PD-L1 inhibition with atezolizumab with rechallenge chemotherapy in patients with sensitive relapse SCLC progressing on first-line… Recruiting

2024-511945-20-00 patients affected by small cell lung cancer (SCLC) 4 2025-01-24
A first-in-human study to determine the safety and tolerability of different doses of GEH200520 Injection and GEH200521 (18F) Injection and … Recruiting

2024-515218-42-00 Irresectable or metastatic solid tumour or a local and 1 2025-01-23
Phase 1 Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancer Recruiting

2024-516526-66-00 Metastatic colorectal cancer and Gastric cancer 1 2025-01-21
Exploratory Study of CAPEcitabine pharmacokinetics and hand-foot syndrome in CES1 variant carriers: the ESCAPE study Recruiting

2024-516788-96-00 Locally advanced or metastatic gastro-intestinal carcin 6 2025-01-20
Amivantamab + Chemotherapy Versus Cetuximab + Chemotherapy in Treatment-naïve Participants with KRAS/NRAS and BRAF Wild-type Colorectal Canc… Recruiting

2024-513852-13-00 KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic 5 2025-01-20
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizum… Recruiting

2023-503675-24-00 Triple-negative Breast Cancer 5 2025-01-17
Dose individualization of chemotherapy in patients with gastrointestinal cancers lacking a specific liver enzyme Recruiting

2023-509963-25-00 Fluoropyrimidine (FP)-naive patients with gastrointesti 4 2025-01-17
A Phase II trial of ginisortamab in participants with metastatic pancreatic ductal adenocarcinoma Recruiting

2024-514129-43-00 Metastatic pancreatic ductal adenocarcinoma 4 2025-01-15
Phase II randomized study evaluating a Pragmatic approach to Adoptive Cell Therapy (ACT) using an IL2 analog (ANV419) vs High dose IL2 after… Recruiting

2023-506400-99-00 Advanced selected solid tumors: melanoma, non-small cel 4 2025-01-15
CASPER-ATG-IPC 2023-015 : Reinforced prophylaxis of GVH in elderly patients with haematological malignancies receiving haploidentical alloge… Recruiting

2023-506648-18-00 haematological malignancies 4 2025-01-14
Efecto de la inmunoterapia en pacientes con cáncer de pulmón de células no pequeñas oligometastásico (número limitado de metástasis) después… Recruiting

2023-508741-40-00 Non-small cell lung cancer 10 2025-01-14
IKS03 in Advanced B cell NHL Recruiting

2024-512415-45-00 Advanced B cell Non-Hodgkin Lymphomas 3 2025-01-14